Should Investors Buy KVUE as Margin Gains Offset Slow Sales Growth?

China's State Administration for Market Regulation unconditionally cleared 14 deals between Oct. 5-11, including Kimberly-Clark's acquisition of Kenvue and ITOCHU's stake purchase in Dentsu Soken, both approved on Oct. 10.

Kimberly-Clark priced a $4.9B senior notes offering to finance its Kenvue acquisition. The offering includes five tranches with varying maturities and interest rates. Proceeds will fund the cash portion of the acquisition, with any remaining used for general corporate purposes. The notes offering is not contingent on the acquisition's completion, but includes a mandatory redemption provision if the deal does not close. The acquisition is expected to close in Q4 2026.

Kimberly-Clark (KMB) received Chinese antitrust approval for its $40B acquisition of Kenvue (KVUE) on Oct. 10, following Brazil's approval. The deal is a major corporate transaction for both companies.

Kimberly-Clark priced a $4.9B offering of senior unsecured notes in five tranches to fund its Kenvue acquisition. The notes, due between 2028 and 2036, will be redeemed if the deal doesn't close by the outside date. Proceeds will cover cash consideration and fees for the acquisition.

Kimberly-Clark priced a $4.9 billion debt offering to finance its Kenvue acquisition. The company sold bonds ahead of the deal, which may impact its financials and investor sentiment.

Kimberly-Clark (KMB) priced a $4.9 billion debt offering for its Kenvue acquisition. The notes, due 2028-2036, will fund the deal. The offering is not tied to the acquisition's completion, but notes may be redeemed if the deal falls through. The notes are for institutional buyers and non-U.S. persons.